Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate

OBJECTIVE: To evaluate the safety, tolerability, and efficacy of ritonavir-boosted saquinavir 1000/100 mg twice daily administered as a 500 mg film-coated tablet in HIV-1-infected patients. METHODS: In this open-label, observational, 24-week survey conducted in 8 European countries, eligible HIV-inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Knechten, Heribert, Lutz, Thomas, Pulik, Piotr, Martin, Teodoro, Tappe, Andre, Jaeger, Hans
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855836/
https://www.ncbi.nlm.nih.gov/pubmed/20428230
http://dx.doi.org/10.1111/j.1753-5174.2009.00028.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855836/
https://www.ncbi.nlm.nih.gov/pubmed/20428230
http://dx.doi.org/10.1111/j.1753-5174.2009.00028.x

Ejemplares similares